Permeases of the sap transporter are required for cathelicidin resistance and virulence of haemophilus ducreyi in humans

Sherri D. Rinker, Xiaoping Gu, Kate R. Fortney, Beth W. Zwickl, Barry Katz, Diane Janowicz, Stanley Spinola, Margaret Bauer

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background. Haemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant. Methods. We generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants. Results. Unlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins. Conclusions. Compared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.

Original languageEnglish
Pages (from-to)1407-1414
Number of pages8
JournalJournal of Infectious Diseases
Volume206
Issue number9
DOIs
StatePublished - Nov 1 2012

Fingerprint

Haemophilus ducreyi
Membrane Transport Proteins
Virulence
Volunteers
Defensins
Peptides
Phenotype
Membranes
CAP18 lipopolysaccharide-binding protein
In Vitro Techniques
peptide permease

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Permeases of the sap transporter are required for cathelicidin resistance and virulence of haemophilus ducreyi in humans. / Rinker, Sherri D.; Gu, Xiaoping; Fortney, Kate R.; Zwickl, Beth W.; Katz, Barry; Janowicz, Diane; Spinola, Stanley; Bauer, Margaret.

In: Journal of Infectious Diseases, Vol. 206, No. 9, 01.11.2012, p. 1407-1414.

Research output: Contribution to journalArticle

@article{80232baab987443d992da7c4cfdbd76e,
title = "Permeases of the sap transporter are required for cathelicidin resistance and virulence of haemophilus ducreyi in humans",
abstract = "Background. Haemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant. Methods. We generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants. Results. Unlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins. Conclusions. Compared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.",
author = "Rinker, {Sherri D.} and Xiaoping Gu and Fortney, {Kate R.} and Zwickl, {Beth W.} and Barry Katz and Diane Janowicz and Stanley Spinola and Margaret Bauer",
year = "2012",
month = "11",
day = "1",
doi = "10.1093/infdis/jis525",
language = "English",
volume = "206",
pages = "1407--1414",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Permeases of the sap transporter are required for cathelicidin resistance and virulence of haemophilus ducreyi in humans

AU - Rinker, Sherri D.

AU - Gu, Xiaoping

AU - Fortney, Kate R.

AU - Zwickl, Beth W.

AU - Katz, Barry

AU - Janowicz, Diane

AU - Spinola, Stanley

AU - Bauer, Margaret

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Background. Haemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant. Methods. We generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants. Results. Unlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins. Conclusions. Compared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.

AB - Background. Haemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant. Methods. We generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants. Results. Unlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins. Conclusions. Compared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.

UR - http://www.scopus.com/inward/record.url?scp=84867562417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867562417&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis525

DO - 10.1093/infdis/jis525

M3 - Article

C2 - 22930807

AN - SCOPUS:84867562417

VL - 206

SP - 1407

EP - 1414

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 9

ER -